Clinical trialNCT07128472RecruitingInterventional

Evaluation of IL 12B Genetic Polymorphism (rs3213094)

SponsorSouth Valley UniversityEnrollment40Psoriasis

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Psoriasis is a skin disorder that is chronic proliferative and inflammatory in nature. Extensor surfaces, scalp, and lumbosacral area are covered in erythematous plaques with silvery scales. The disease can also impair the eyes and joints. It has no cure. Because of their low quality of life, many psoriasis patients experience depression. In addition to the cutaneous manifestations, it is associated with an increased risk of psoriatic arthritis, depression and cardiovascular disease.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Eisa Mohammed Hegazy, Professor
Dermatology, Venereology and Andrology. Qena Faculty of Medicine,South Valley University
Study Director
clinicaltrials.gov ↗
Mohamed Hosny Hassan, Professor
Medical Biochemistry Department,Qena Faculty of Medicine,south valley university
Principal Investigator
clinicaltrials.gov ↗
Moustafa Adam Ali El Taieb, Professor
Dermatology, Venereology and Andrology. Faculty of Medicine,Qena University
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Egypt

Qina University Hospital, South Valley University Hospital
Qina, Egypt
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Adalimumab

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Aug 2025
Primary completion: 20 Jan 2026
Completion: 1 Feb 2026
Last update posted: 19 Aug 2025
Registered enrollment: 40
Registry id: NCT07128472

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.